UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Denosumab in Men Receiving Androgen-Deprivation Therapy for Prostate Cancer

The New England journal of medicine, 2009-08, Vol.361 (8), p.745-755

2009

Volltextzugriff (PDF)

MicroRNA expression profiling in prostate cancer

Cancer research (Chicago, Ill.), 2007-07, Vol.67 (13), p.6130-6135

2007

Volltextzugriff (PDF)

Screening and Prostate-Cancer Mortality in a Randomized European Study

The New England journal of medicine, 2009-03, Vol.360 (13), p.1320-1328

2009

Volltextzugriff (PDF)

Adaptive and non-adaptive gene expression responses in prostate cancer during androgen deprivation

PloS one, 2023-02, Vol.18 (2), p.e0281645-e0281645

2023

Volltextzugriff (PDF)

The importance of LDL and cholesterol metabolism for prostate epithelial cell growth

PloS one, 2012-06, Vol.7 (6), p.e39445-e39445

2012

Volltextzugriff (PDF)

Darolutamide and Survival in Metastatic, Hormone-Sensitive Prostate Cancer

The New England journal of medicine, 2022-03, Vol.386 (12), p.1132-1142

2022

Volltextzugriff (PDF)

AR and ERG drive the expression of prostate cancer specific long noncoding RNAs

Oncogene, 2020-07, Vol.39 (30), p.5241-5251

2020

Volltextzugriff (PDF)

Novel prostate cancer susceptibility gene SP6 predisposes patients to aggressive disease

Prostate cancer and prostatic diseases, 2021-12, Vol.24 (4), p.1158-1166

2021

Volltextzugriff (PDF)

The Role of Genetic Markers in the Management of Prostate Cancer

European urology, 2012-10, Vol.62 (4), p.577-587

2012

Volltextzugriff (PDF)

Cost-effectiveness analysis of PSA-based mass screening: Evidence from a randomised controlled trial combined with register data

PloS one, 2019-11, Vol.14 (11), p.e0224479-e0224479

2019

Volltextzugriff (PDF)

Use of aspirin, but not other non-steroidal anti-inflammatory drugs is associated with decreased prostate cancer risk at the population level

European journal of cancer (1990), 2013-03, Vol.49 (4), p.938-945

2013

Volltextzugriff (PDF)

Cholesterol-Lowering Drugs and Prostate Cancer Risk: A Population-based Case-Control Study

Cancer epidemiology, biomarkers & prevention, 2007-11, Vol.16 (11), p.2226-2232

2007

Volltextzugriff (PDF)

TMPRSS2:ERG Fusion Identifies a Subgroup of Prostate Cancers with a Favorable Prognosis

Clinical cancer research, 2008-06, Vol.14 (11), p.3395-3400

2008

Volltextzugriff (PDF)

Microseminoprotein-Beta Expression in Different Stages of Prostate Cancer

PloS one, 2016-03, Vol.11 (3), p.e0150241-e0150241

2016

Volltextzugriff (PDF)

What Is the Most Bothersome Lower Urinary Tract Symptom? Individual- and Population-level Perspectives for Both Men and Women

European urology, 2014-06, Vol.65 (6), p.1211-1217

2014

Volltextzugriff (PDF)

Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up

The Lancet (British edition), 2014-12, Vol.384 (9959), p.2027-2035

2014

Volltextzugriff (PDF)

Effects of Denosumab on Bone Mineral Density in Men Receiving Androgen Deprivation Therapy for Prostate Cancer

The Journal of urology, 2009-12, Vol.182 (6), p.2670-2676

2009

Volltextzugriff (PDF)

Blood glucose, glucose balance, and disease-specific survival after prostate cancer diagnosis in the Finnish Randomized Study of Screening for Prostate Cancer

Prostate cancer and prostatic diseases, 2019-09, Vol.22 (3), p.453-460

2019

Volltextzugriff (PDF)

Antidiabetic Medication and Prostate Cancer Risk: A Population-based Case-Control Study

American journal of epidemiology, 2008-10, Vol.168 (8), p.925-931

2008

Volltextzugriff (PDF)

MiRNA Profiles in Lymphoblastoid Cell Lines of Finnish Prostate Cancer Families

PloS one, 2015-05, Vol.10 (5), p.e0127427

2015

Volltextzugriff (PDF)

Silodosin Therapy for Lower Urinary Tract Symptoms in Men with Suspected Benign Prostatic Hyperplasia: Results of an International, Randomized, Double-Blind, Placebo- and Active-Controlled Clinical Trial Performed in Europe

European urology, 2011-03, Vol.59 (3), p.342-352

2011

Volltextzugriff (PDF)

Histological inflammation and risk of subsequent prostate cancer among men with initially elevated serum prostate‐specific antigen (PSA) concentration in the Finnish prostate cancer screening trial

BJU international, 2013-10, Vol.112 (6), p.735-741

2013

Volltextzugriff (PDF)

Screening history and risk of death from prostate cancer: a nested case–control study within the screening arm of the Finnish Randomized Study of Screening for Prostate Cancer (FinRSPC)

Cancer causes & control, 2024-04, Vol.35 (4), p.695-703

2024

Volltextzugriff (PDF)

Prostate cancer-specific survival among warfarin users in the Finnish Randomized Study of Screening for Prostate Cancer

BMC cancer, 2017-08, Vol.17 (1), p.585-585, Article 585

2017

Volltextzugriff (PDF)

Nocturia Frequency, Bother, and Quality of Life: How Often Is Too Often? A Population-Based Study in Finland

European urology, 2010-03, Vol.57 (3), p.488-498

2010

Volltextzugriff (PDF)

1 – 25 von 457

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(427)
Mit Volltextzugriff
(349)

Publikationsform

Sprache

Englisch
(455)
Japanisch
(66)
Finnisch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(370)
Life Sciences & Biomedicine
(358)
Humans
(327)
Male
(325)
Middle Aged
(209)
Aged
(207)
Biological And Medical Sciences
(205)
Medical Sciences
(202)
Urology & Nephrology
(195)
Nephrology. Urinary Tract Diseases
(152)
Urinary Tract. Prostate Gland
(137)
Prostate Cancer
(136)
Oncology
(111)
Tumors Of The Urinary System
(106)
Tumors
(90)
Finland - Epidemiology
(80)
Prostatic Neoplasms - Genetics
(79)
Urology
(73)
Aged, 80 And Over
(70)
Prostatic Neoplasms - Pathology
(70)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(349)
Journals@Ovid
(236)
IngentaConnect
(226)
EZB Electronic Journals Library
(176)
ScienceDirect
(161)
Publisher or Other Site
(157)
IngentaConnect Journals
(152)
Wiley Online Library
(88)
Wiley Online Library
(80)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(37)
Taylor & Francis
(36)
Taylor & Francis E-Journals
(35)
Taylor & Francis Journals Auto-Holdings Collection
(35)
Springer Online Journals
(34)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(24)
Nature
(22)
Oxford Journals
(12)
Oxford Journals 2020 Medicine
(10)
JSTOR
(8)
Nexis Uni
(8)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

The Journal Of Urology
(77)
European Urology
(42)
The Prostate
(22)
International Journal Of Cancer
(21)
Scandinavian Journal Of Urology And Nephrology
(18)
Bju International
(17)
Urology
(17)
Cancer Research
(16)
Clinical Cancer Research
(12)
Journal Of Clinical Oncology
(12)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Denosumab in Men Receiving Androgen-Deprivation Therapy for Prostate Cancer

MicroRNA expression profiling in prostate cancer

Screening and Prostate-Cancer Mortality in a Randomized European Study

Adaptive and non-adaptive gene expression responses in prostate cancer during androgen deprivation

The importance of LDL and cholesterol metabolism for prostate epithelial cell growth

Darolutamide and Survival in Metastatic, Hormone-Sensitive Prostate Cancer

AR and ERG drive the expression of prostate cancer specific long noncoding RNAs

Novel prostate cancer susceptibility gene SP6 predisposes patients to aggressive disease

The Role of Genetic Markers in the Management of Prostate Cancer

Cost-effectiveness analysis of PSA-based mass screening: Evidence from a randomised controlled trial combined with register data

Use of aspirin, but not other non-steroidal anti-inflammatory drugs is associated with decreased prostate cancer risk at the population level

Cholesterol-Lowering Drugs and Prostate Cancer Risk: A Population-based Case-Control Study

TMPRSS2:ERG Fusion Identifies a Subgroup of Prostate Cancers with a Favorable Prognosis

Microseminoprotein-Beta Expression in Different Stages of Prostate Cancer

What Is the Most Bothersome Lower Urinary Tract Symptom? Individual- and Population-level Perspectives for Both Men and Women

Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up

Effects of Denosumab on Bone Mineral Density in Men Receiving Androgen Deprivation Therapy for Prostate Cancer

Blood glucose, glucose balance, and disease-specific survival after prostate cancer diagnosis in the Finnish Randomized Study of Screening for Prostate Cancer

Antidiabetic Medication and Prostate Cancer Risk: A Population-based Case-Control Study

MiRNA Profiles in Lymphoblastoid Cell Lines of Finnish Prostate Cancer Families

Silodosin Therapy for Lower Urinary Tract Symptoms in Men with Suspected Benign Prostatic Hyperplasia: Results of an International, Randomized, Double-Blind, Placebo- and Active-Controlled Clinical Trial Performed in Europe

Histological inflammation and risk of subsequent prostate cancer among men with initially elevated serum prostate‐specific antigen (PSA) concentration in the Finnish prostate cancer screening trial

Screening history and risk of death from prostate cancer: a nested case–control study within the screening arm of the Finnish Randomized Study of Screening for Prostate Cancer (FinRSPC)

Prostate cancer-specific survival among warfarin users in the Finnish Randomized Study of Screening for Prostate Cancer

Nocturia Frequency, Bother, and Quality of Life: How Often Is Too Often? A Population-Based Study in Finland

Suchergebnisse filtern